According to New Scientist, recent tests on mice has demonstrated that by injecting a CRISPR Cas 9 protein and a guiding RNA sequence, they were able to drastically reduce cholesterol levels in the animals, with the effects becoming permanent. Albeit CRISPR keeps improving, reducing the number of potentially dangerous errors it may introduce means that human trials are not expected for at least another decade.
In 2005, it was discovered that a few people naturally have very low cholesterol levels, thanks to mutations that prevent their livers from making a protein called PCSK9. “They have a lower incidence of cardiovascular disease and no apparent side effects whatsoever,” says Gilles Lambert at the University of Reunion Island, who studies PCSK9.
The PCSK9 protein normally circulates in the blood, where it degrades a protein found on the surface of blood vessels. This second protein removes LDL cholesterol from the blood: the faster it is degraded by PCSK9, the higher a person’s cholesterol levels. But people who lack PCSK9 due to genetic mutations have more of this LDL-removal protein, and therefore less cholesterol in their blood.
|Artificial Graphene Retina Can Interface with Optical Nerve|
|Your Beautiful Body is Made Out of Garbage|
|Woman Receives Donation from Mysterious Stranger to Pay for Her Treatment|
|"With CRISPR, what lines do we absolutely not cross?"|
|“The direction of the cost of storage is less clear and depends on metals prices.”|
|Facebook, Twitter Users Could Face Insurance Hikes|
|“The era of climate wars has begun.”|
|How to Avoid Jury Duty|
|The (Very Scary) People of Public Transit|
|“Bias, error, and misuse of Artificial Intelligence technologies.”|
|“We need to make algorithms transparent, regulated, and forgiving of the flawed creatures that converse with them.”|
|Naked Preacher Lady [NSFW]|
|CaptchaTweet: Write Tweets in Captcha Form|
|Boardwalk Empire: Time Lapse Video|
|Fake Name Generator|